Monovisc 88 MG/4 ML syringe 4ML
Ended Awarded
- Contract number
- SPE2DB26FWVWE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,891
Award facts
- Contract value 100% obligated
- $8,890.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $8,890.90 to AmerisourceBergen Drug Corp for the supply of MONOVISC 88 mg/4 ml syringes (4 ml) under a firm fixed price contract structure. The award, issued on November 7, 2025, with an ultimate completion date of November 10, 2025, represents a non-competitive set-aside delivery order supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor and healthcare solutions provider for military and veteran healthcare systems, with performance of this order occurring at the company's corporate office location.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent IDC enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. As a child contract of this expansive vehicle, the current delivery order exemplifies the flexibility and scope of the DLA's pharmaceutical procurement strategy to serve the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DB26FWVWE?
SPE2DB26FWVWE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DB26FWVWE worth?
The government has obligated $8,891 on SPE2DB26FWVWE.
Is contract SPE2DB26FWVWE an order under another contract?
Yes. SPE2DB26FWVWE is a delivery order under SPE2DB25D3012, an indefinite delivery contract.
Was contract SPE2DB26FWVWE competed?
The extent of competition for SPE2DB26FWVWE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award